CRT 2026

BEYOND THE GUIDELINES | DE-ESCALATION OF ANTIPLATELET THERAPY

Moderator(s)

• 

  C. Michael Gibson, MD

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure(s): Amgen, Chiesi, Angel/Avertix Medical, Anthos Therapeutics, Janssen Pharmaceuticals, Johnson & Johnson Corporation, Bayer Corporation, Corsear, MashUp MD, Bioclinica, MD Magazine, Boehringer Ingelheim, Merck, Boston Clinical Research Institute, MjHeal: Consulting Fees (e.g., advisory boards) (Ongoing); HeartBeam, nference, Flow Therapy, Celecor, Fortress Biotech, TribeMD (Co-Founder), Generable and Lexaria: Stock Options [in privately held companies] (Ongoing); Johnson & Johnson Corporation, CSL Behring, SCAD Alliance, NACAM Trial (Sub-award - 5R01HL151996-05), and Janssen Pharmaceuticals.: Grant/Research Support (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing)
• 

  Arnold H. Seto, MD, MPA

  Director of Cardiac Cath Lab
  Long Beach Veterans Affairs Medical Center
  Long Beach, California, United States

  Disclosure(s): Frond Medical: Stock-privately held company (Ongoing); GE Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Maquet Getinge Group: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merit Medical Systems Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Summacor: Stock-privately held company (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

• 

  Usman Baber, MD, MS

  Professor of Medicine
  University of Oklahoma Health Sciences Center
  Oklahoma City, Oklahoma, United States

  Disclosure(s): AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Adnan Kastrati, MD

  Senior Consultant, Head of Catheterization Laboratory
  Deutsches Herzzentrum Muenchen
  Munich, Bayern, Germany

  Disclosure(s): No financial relationships to disclose
• 

  Manoj Kesarwani, MD

  Health Sciences Clinical Associate Professor
  University of California, Davis School of Medicine
  Sacramento, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Sanjay Kaul, MD

  Attending Cardiologist
  Cedars-Sinai Medical Center
  Los Angeles, California, United States

  Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Terminated, October 1, 2023); Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Bayer HealthCare: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Terminated, November 1, 2023); medtronic.: Consulting Fees (e.g., advisory boards) (Terminated, August 1, 2023); Merck Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI

  Interventional, structural, and endovascular cardiologist
  Heart and Vascular Institute (HVI) at Tampa General Hospital (TGH) in Tampa, FL
  Wesley Chapel, Florida, United States

  Disclosure(s): No financial relationships to disclose
• 

  Ron Waksman, MD, MSCAI

  Director, Cardiovascular Research and Advanced Education
  MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
  Washington, District of Columbia, United States

  Disclosure information not submitted.